ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The Biology of Aging: Innovations in Cellular Rejuvenation with Life Biosciences’ Dr. Sharon Rosenzweig-Lipson"
Episode Synopsis
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Sharon Rosenzweig-Lipson, PhD, Chief Scientific Officer (CSO) at Life Biosciences, a company advancing cellular rejuvenation gene therapies to treat age-related diseases.
The company is targeting eye diseases like glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION).
Dr. Rosenzweig-Lipson has held leadership positions in both big pharma and small biotechnology companies over the course of her 30+ year career, which has included roles at American Cyanamid (now Pfizer), advancing programs from the early exploratory phase through to Phase IIB. Afterwards, she spent the next 12 years at AgeneBio where she served as Vice President of R&D.
Dr. Rosenzweig-Lipson is globally recognized for her scientific and strategic leadership, having led global translational alliances. She received her BA in the biological basis of behavior from the University of Pennsylvania and her PhD in psychology (in behavioral neuroscience) from Harvard University.
Tune in to hear about novel approaches designed to reverse cellular aging, including Life Bioscience’s work in advancing a first-of-its kind gene therapy.
For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media
Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured
The company is targeting eye diseases like glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION).
Dr. Rosenzweig-Lipson has held leadership positions in both big pharma and small biotechnology companies over the course of her 30+ year career, which has included roles at American Cyanamid (now Pfizer), advancing programs from the early exploratory phase through to Phase IIB. Afterwards, she spent the next 12 years at AgeneBio where she served as Vice President of R&D.
Dr. Rosenzweig-Lipson is globally recognized for her scientific and strategic leadership, having led global translational alliances. She received her BA in the biological basis of behavior from the University of Pennsylvania and her PhD in psychology (in behavioral neuroscience) from Harvard University.
Tune in to hear about novel approaches designed to reverse cellular aging, including Life Bioscience’s work in advancing a first-of-its kind gene therapy.
For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media
Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured
More episodes of the podcast Xtalks Life Science Podcast
Restoring Lost Synapses in ALS, Fragile X and More with Spinogenix’s Dr. Peter Vanderklish
19/11/2025
Teaching the Pancreas to Heal Itself: Dr. Juan Domínguez-Bendala on Regenerative Diabetes Research
15/10/2025
In God we trust